156 related articles for article (PubMed ID: 23498325)
1. Radiotherapy and chemotherapy are associated with improved outcomes over surgery and chemotherapy in the management of limited-stage small cell esophageal carcinoma.
Meng MB; Zaorsky NG; Jiang C; Tian LJ; Wang HH; Liu CL; Wang J; Tao Z; Sun Y; Wang J; Pang QS; Zhao LJ; Yuan ZY; Ping W
Radiother Oncol; 2013 Mar; 106(3):317-22. PubMed ID: 23498325
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of 126 patients with primary small cell carcinoma of the esophagus].
Lü JM; Liang J; Wang JW; He J; Xiao ZF; Zhang HX; Chen DF; Feng QF; Wang LH
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):121-5. PubMed ID: 19538888
[TBL] [Abstract][Full Text] [Related]
3. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
4. [Surgical treatment and prognostic analysis of 109 patients with primary esophageal small cell carcinoma].
Zhang BH; Yang WJ; Zhao L; He J; Wang YG; Zhang HT
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):698-702. PubMed ID: 23159085
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of different treatments of limited-stage small-cell esophageal carcinoma and associated prognostic factor analysis.
Ding J; Ji J; Zhu W; Zhou K; Han J; Zhang Y; Yu C; Li T; Tao G; Ji F; Zhou X; Pan P
Dis Esophagus; 2013; 26(7):696-702. PubMed ID: 23317069
[TBL] [Abstract][Full Text] [Related]
6. Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base.
Wong AT; Shao M; Rineer J; Osborn V; Schwartz D; Schreiber D
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27860114
[TBL] [Abstract][Full Text] [Related]
7. Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma.
Wang HH; Zaorsky NG; Meng MB; Wu ZQ; Zeng XL; Jiang B; Jiang C; Zhao LJ; Yuan ZY; Wang P
Onco Targets Ther; 2015; 8():437-44. PubMed ID: 25709477
[TBL] [Abstract][Full Text] [Related]
8. Surgery versus radiotherapy for limited-stage small cell esophageal carcinoma: a multicenter, retrospective, cohort study in China (ChiSCEC).
Zhu J; Wang Y; Sun H; Zhang Y; Zhang W; Shen W; Yang N; Tan B; Su X; Li L; Dong W; Ma J; Zhang J; Zhao L; Sun D; Yang P; Peng L; Li B; Huang W; Wang Q; Liao Z
Int J Surg; 2024 Feb; 110(2):956-964. PubMed ID: 37995095
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcome and prognostic factors in non-metastatic esophageal carcinoma.
Saglam EK; Kilciksiz S; Ozseker N; Karadeniz A; Oral EN; Kizir A
Saudi Med J; 2007 Jul; 28(7):1086-90. PubMed ID: 17603717
[TBL] [Abstract][Full Text] [Related]
10. Nonsurgical management of esophageal adenocarcinoma.
Gujral DM; Hawkins MA; Leonulli BG; Ashley S; Chau I; Cunningham D; Tait D
Clin Colorectal Cancer; 2011 Sep; 10(3):165-70. PubMed ID: 21855037
[TBL] [Abstract][Full Text] [Related]
11. Primary small cell carcinoma of the esophagus.
Lv J; Liang J; Wang J; Wang L; He J; Xiao Z; Yin W
J Thorac Oncol; 2008 Dec; 3(12):1460-5. PubMed ID: 19057273
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
[TBL] [Abstract][Full Text] [Related]
13. A Retrospective Study of 52 Patients With Primary Small Cell Carcinoma of the Esophagus Treated With Radical Surgery.
Fan N; Wang Z; Huang Y; Tan Z; Yang H; Lin P
Cancer Control; 2021; 28():10732748211027147. PubMed ID: 34155924
[TBL] [Abstract][Full Text] [Related]
14. [A clinicopathological study of small-cell esophageal carcinoma].
Li X; Zhang D; Lai R
Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):395-7. PubMed ID: 9387286
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of 33 cases of primary esophageal small cell carcinoma].
Duan HB; Wu HY; Su XD; Zeng CG; Dai WQ; Huang L
Ai Zheng; 2007 Jul; 26(7):771-4. PubMed ID: 17626757
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy.
Kader AS; Lim JT; Berthelet E; Petersen R; Ludgate D; Truong PT
Am J Clin Oncol; 2007 Oct; 30(5):492-7. PubMed ID: 17921709
[TBL] [Abstract][Full Text] [Related]
17. Treatment and prognosis of limited disease primary small cell carcinoma of esophagus.
Chen SB; Yang JS; Yang WP; Weng HR; Li H; Liu DT; Chen YP
Dis Esophagus; 2011 Feb; 24(2):114-9. PubMed ID: 21040151
[TBL] [Abstract][Full Text] [Related]
18. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
Chang DT; Chapman C; Shen J; Su Z; Koong AC
Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
[TBL] [Abstract][Full Text] [Related]
19. Prognostic analysis of limited-stage small cell lung cancer after chemoradiotherapy.
Su J; Zhu S; Liu Z; Jing S; Shen W; Li J
Onkologie; 2012; 35(6):362-7. PubMed ID: 22722457
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
